Skip to main content
  • John Buse, MD, PhD-interviewed-stem-cell-treatment-Type-1

    UNC Participates in First Nationwide Network to Study Rare Forms of Diabetes

    John Buse, MD, PhD, will lead the UNC-Chapel Hill site for a collaborative NIH research effort to discover new forms of diabetes, understand their differences, and identify their causes. UNC-Chapel Hill is participating in a nationwide study funded by the National Institutes of Health that will seek to discover the cause of several unusual forms of diabetes. For years, doctors an … Read more

  • August- Grants and Funding

    Department of Medicine Grants & Funding: August 1 – August 31, 2020

    Division of Endocrinology and Metabolism Laura Young, MD, PhD, and Katrina Donahue, MD, MPH, received a PCORI grant to study the impact of COVID-19 on glucose monitoring in diabetes patients. Division of Pulmonary and Critical Care Medicine Silvia Kreda, PhD, was awarded an NIH SBIR Phase II grant to study molecules that enhance delivery of therapeutic oligonucleotides to correct … Read more

  • door-sign-glucose-precautions-vcag-DTT

    Medicine’s “Value-Care Action Group” Introduces Specialized Inpatient Diabetes Management Services

    Hospitalized patients with diabetes are dependent on hospital staff to monitor blood glucose, administer medications and deliver meals in a coordinated manner. Inconsistency in the timing of these tasks can increase the risk for hyperglycemia and hypoglycemia. The UNC Department of Medicine’s Value Care Action Group (VCAG) has been working with the Division of Endocrinology to im … Read more

  • laura-young

    Donahue, Young Receive PCORI Grant to Study COVID-19 Impact On Glucose Monitoring in Diabetes Patients

    Katrina Donahue, MD, MPH, professor and vice chair for research in the department of family medicine, and Laura Young, MD, PhD, associate professor in the division of endocrinology and metabolism, are co-primary researchers of a study to investigate the impact of COVID-19 on glucose monitoring in primary care patients with diabetes. The team was awarded $500,000 from the Patient- … Read more

  • laura-young

    Young, Bergamo Publish Studies On Continuous Glucose Monitoring in Elders and in Youth With Type 1 Diabetes

    Laura Young, MD, PhD, and Katherine Bergamo, FNP-C, are local principal investigators for two papers recently published in the Journal of American Medicine Association. Young, associate professor in the division of endocrinology and metabolism, published the Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes. In this randomized clinical t … Read more

  • Sriram Machineni, MD

    Machineni Says Eating Meals Earlier in the Day Could Impact Weight Loss

    Sriram Machineni, MD, assistant professor of medicine in the division of endocrinology and metabolism was interviewed for a Pop Sugar article about weight loss and timing of meals. “A recent study may have confirmed just that when it showed that people who ate closer to the time when their bodies released melatonin — “at the onset of sleep,” said Machineni in the article, “who ha … Read more

  • morgan-simonds-jones

    Transitioning Diabetes Patients To Virtual Care During Pandemic Shows Positive Results

    In a journal article published in Diabetes Technology & Therapeutics, first author Morgan Jones, MD, assistant professor of medicine in the division of endocrinology and metabolism, said transitioning to virtual care models does not limit the glycemic outcomes of inpatient diabetes care. Telehealth visits for patients with diabetes appear to show positive results, according t … Read more

  • laura-young-newsworthy-Nov-2021

    Young Shows Use of Continuous Glucose Monitoring Reduces Hypoglycemia in Older Adults with Type 1 Diabetes

    Laura Young, MD, PhD, associate professor of medicine in the division of endocrinology and metabolism, was UNC’s principal investigator for a six-month clinical trial that shows the use of continuous glucose monitoring reduces serious levels of hypoglycemia compared with standard monitoring by daily use of blood glucose finger-stick test strips. Learn more from the UNC Health and … Read more

  • John Buse, MD, PhD-interviewed-stem-cell-treatment-Type-1

    Buse, Site Leader For Effort Gathering Big Data to Accelerate COVID-19 fight

    A nationwide collaboration of clinicians, informaticians, and other biomedical researchers aims to turn data from hundreds of thousands of medical records from coronavirus patients into effective treatments and predictive analytical tools that could help lessen or end the global pandemic. Through the National COVID Cohort Collaborative, about 60 clinical institutions affiliated w … Read more

  • morgan-simonds-jones

    Jones Publishes Article Demonstrating Inpatient Transition to Virtual Care During COVID-19

    Morgan S. Jones, MD, assistant professor of medicine in the division of endocrinology and metabolism, is lead author on a new paper published in Diabetes Technology and Therapeutics, reporting on novel approaches to the COVID-19 outbreak that leveraged UNC’s diabetes co-management service, initiated in July, 2019. Driven by the need to reduce the use of PPE and exposure for patie … Read more

  • john-buse

    Buse Explains What People with Diabetes Need to Know About COVID-19 

    John Buse, MD, PhD, chief of the division of endocrinology and metabolism, director of the UNC Diabetes Care Center, and director of the North Carolina Translational and Clinical Sciences Institute, explains how diabetes is linked to more severe cases of COVID-19 in a new UNC Health article. He also encourages patients not to skip their diabetes-related visits with primary care p … Read more

  • John Buse, MD, PhD-interviewed-stem-cell-treatment-Type-1

    Buse Discusses the Future of Insulin

    John Buse, MD, MPH, was interviewed by Endocrine Today describing what the future of insulin may look like. The article recognizes novelty treatments to manage diabetes, including the smart insulin patch that “leverages chemistry to release insulin in parallel with fluctuations of glucose.” Buse says that if “successfully translated to human use, it could dramatically reduce the … Read more